IN8bio, Inc. (INAB)
1.09
-0.05
(-4.39%)
USD |
NASDAQ |
Sep 09, 12:39
IN8bio Market Cap : 10.74M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 11.23M |
| September 04, 2026 | 11.82M |
| September 03, 2026 | 11.43M |
| September 02, 2026 | 10.84M |
| September 01, 2026 | 10.74M |
| August 31, 2026 | 10.84M |
| August 28, 2026 | 10.20M |
| August 27, 2026 | 10.25M |
| August 26, 2026 | 11.68M |
| August 25, 2026 | 11.53M |
| August 24, 2026 | 11.63M |
| August 21, 2026 | 12.61M |
| August 20, 2026 | 11.92M |
| August 19, 2026 | 11.82M |
| August 18, 2026 | 11.23M |
| August 17, 2026 | 10.94M |
| August 14, 2026 | 10.84M |
| August 13, 2026 | 11.63M |
| August 12, 2026 | 9.838M |
| August 11, 2026 | 10.35M |
| August 10, 2026 | 9.616M |
| August 07, 2026 | 9.642M |
| August 06, 2026 | 9.556M |
| August 05, 2026 | 9.743M |
| August 04, 2026 | 9.46M |
| Date | Value |
|---|---|
| August 03, 2026 | 9.453M |
| July 31, 2026 | 10.19M |
| July 30, 2026 | 10.63M |
| July 29, 2026 | 10.54M |
| July 28, 2026 | 10.93M |
| July 27, 2026 | 11.72M |
| July 24, 2026 | 11.82M |
| July 23, 2026 | 11.72M |
| July 22, 2026 | 12.11M |
| July 21, 2026 | 12.21M |
| July 20, 2026 | 12.41M |
| July 17, 2026 | 13.10M |
| July 16, 2026 | 13.59M |
| July 15, 2026 | 14.18M |
| July 14, 2026 | 13.59M |
| July 13, 2026 | 13.20M |
| July 10, 2026 | 13.10M |
| July 09, 2026 | 13.79M |
| July 08, 2026 | 13.59M |
| July 07, 2026 | 13.69M |
| July 06, 2026 | 14.18M |
| July 02, 2026 | 13.98M |
| July 01, 2026 | 13.98M |
| June 30, 2026 | 13.88M |
| June 29, 2026 | 14.08M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.91B |
| Oncolytics Biotech, Inc. | 100.76M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.345B |
| Anixa Biosciences, Inc. | 95.66M |
Market Cap Related Metrics
| Price to Book Value | 0.5849 |
| Price | 1.09 |
| Earnings Yield | -170.9% |